Chief Medical Officer: Oncology Clinical Development Leader

PharmAbcine Inc.; Brisbane; On-site; AUD 360,000 - 600,000; Full time

Job summary

PharmAbcine, Inc. in Brisbane, Australia seeks a Chief Medical Officer to lead the clinical development strategy across oncology and related diseases.

You will oversee trial design, regulatory interactions, and IND/MAA submissions, and guide medical affairs and biometrics in partnership with the CEO and executive team. The CMO will manage clinical operations and patient advocacy, mentor senior staff, and represent the company to investors and partners.

Qualifications

• The ideal candidate will offer an MD with Oncology Board certification and extensive pharma/biotech sponsor experience.
• Proven leadership of clinical groups including medical affairs and operations.
• Strong track record in Phase I–IV trials and regulatory filings (INDs, BLAs, MAAs).

Responsibilities

• Direct development of clinical strategies and plans for oncology and eye diseases.
• Oversee regulatory strategies and interactions with Health Authorities.
• Analyze and interpret clinical trial data and report results.
• Lead interactions with academic leaders, investigators and groups.
• Represent the company to investors, regulators and partners.
• Oversee Clinical Research, Clinical Operations, Medical Affairs and Biometrics teams.

Skills

Fluent English

Leadership

Strategic thinking

Regulatory knowledge

Education

MD with Board Certification in Medical Oncology

Medical degree with Oncology training

Tools

IND/MAA submissions

Job description

PharmAbcine, Inc. in Brisbane, Australia seeks a Chief Medical Officer to lead the clinical development strategy across oncology and related diseases.

You will oversee trial design, regulatory interactions, and IND/MAA submissions, and guide medical affairs and biometrics in partnership with the CEO and executive team. The CMO will manage clinical operations and patient advocacy, mentor senior staff, and represent the company to investors and partners.